ASPREE Project News
Aspirin and anemia risk in older adults
Low-dose aspirin may increase anemia risk in healthy older adults: study A new study analysing data from the...
Findings continue to impact aspirin guidelines
U.S. medical expert group latest to cite ASPREE results in guidelines Major findings from the ASPREE trial have been...
Blood pressure variability associated with increased risk of dementia, especially in men
High long term blood pressure variability (BPV) in older adults, particularly men, is associated with an increased...
Update: ASPREE-XT study visits and COVID-19
Important information about ASPREE-XT study visits and COVID-19 ANNOUNCEMENT In light of public health...
Aspirin and cognitive decline
Daily low-dose aspirin does not prevent cognitive decline in healthy older adults PRESS RELEASE: April...
Low-dose aspirin and depression
ASPREE-D sub-study finds daily aspirin not protective against late-life depression PRESS RELEASE: June 4, 2020...
Observational statin study in ASPREE participants
Statins may prevent heart attacks and strokes but may not prolong life free of disability PRESS RELEASE...
Meet the team: Introducing a US ASPREE investigator
Professor Mike Ernst Michael E. Ernst is a clinical professor at the University of Iowa (UI) College of Pharmacy...
Aspirin and major gastrointestinal bleeding risk
New analysis identifies potential risk of major GI bleeding in older adults A closer analysis of data from the...
ASPREE-XT (eXTension) study funded to determine longer-term effects of aspirin on health
Landmark study to assess long-term health risks and benefits of prior aspirin use in elderly ANNOUNCEMENT: Landmark...